0920 T&L Financials 02. qxd 15 6 09 16:11 Page 161 Notes to the parent company financial statements 6 Creditors due within one year 31 March 2009 2008 m m Amounts owed to subsidiary undertakings 126 563 Other creditors 5 1 Accruals and deferred income 4 21 Total 135 585 The effective interest rate applicable to amounts owed to subsidiary undertakings at 31 March 2009 is 1.6% 2008 4.8%.
Amounts owed to subsidiary undertakings are repayable on demand.
7 Creditors due after more than one year 31 March 2009 2008 m m Amounts owed to subsidiary undertakings 512 426 Preference shares 2 2 Total 514 428 The effective interest rate applicable to amounts owed to subsidiary undertakings at 31 March 2009 is 6.5% 2008 6.5%.
Amounts owed to subsidiary undertakings at year end mature after more than three years 2008 mature after more than four years.
8 Deferred tax Deferred tax charged to profit in the year was 2 million 2008 6 million.
9 Provisions for liabilities and charges Restructuring Other Total m m m At 31 March 2008 213 Charged to the profit and loss account 1 1 Utilised in the year 1 1 At 31 March 2009 213 Provisions primarily relate to restructuring as a result of the disposal of the five European starch plants and are expected to be utilised within the next 12 months.
10 Contingent liabilities 31 March 2009 2008 m m Loans and overdrafts of subsidiaries, joint ventures and associates and former subsidiaries guaranteed 1 407 1 039 Guarantees given in respect of drawn and undrawn loans and overdrafts by Tate & Lyle PLC were 2,807 million at 31 March 2009 2008 2,041 million.
Other trade guarantees have been given in the normal course of business by Tate & Lyle PLC at both 31 March 2009 and 31 March 2008.
These are excluded from the figures given above and are in respect of Revenue and Customs and the Rural Payments Agency for Agricultural Produce bonds, ECGD recourse agreements, letters of credit and tender and performance bonds.
Tate & Lyle Annual Report 2009 161 STATUTORY INFORMATION HOW WE RUN THE BUSINESS HOW WE PERFORMED WHAT WE DO OVERVIEW OF THE YEAR
